Publications by authors named "Jonathan Serody"

Claim this Profile
A
A Tacrolimus Population Pharmacokinetic Model for Adult Allogeneic Hematopoietic Cell Transplant Recipients Provides Clinical Opportunities for Precision Dosing.
Tyler C Dunlap, Jing Zhu, Daniel L Weiner, Ryan M Kemper, Susanna C DeVane, Jonathan S Serody

Clin Pharmacokinet· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A simple and efficient method for the robust expansion of human ILC2s to prevent acute GVHD.
Danny W Bruce, Sonia J Laurie, Yan Xing, Heather E Stefanski, Keli L Hippen, Jonathan S Serody

Blood Adv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infectious Complications Following CD30 Chimeric Antigen Receptor T-cell Therapy in Adults.
Felicia Cao, Yueling Xiu, Michael Mohnasky, Jonathan S Serody, Paul Armistead

Open Forum Infect Dis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-specific surface marker-independent targeting of tumors through nanotechnology and bioorthogonal glycochemistry.
Hyesun Hyun, Bo Sun, Mostafa Yazdimamaghani, Albert Wielgus, Yue Wang, Jonathan S Serody

J Clin Invest· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial.
Kim A Reiss, Mathew G Angelos, E Claire Dees, Yuan Yuan, Naoto T Ueno, Jonathan S Serody

Nat Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Tumor microenvironment immunomodulation by nanoformulated TLR 7/8 agonist and PI3k delta inhibitor enhances therapeutic benefits of radiotherapy" [Biomaterials 312 (2025) 122750.
Mostafa Yazdimamaghani, Oleg V Kolupaev, Chaemin Lim, Duhyeong Hwang, Sonia J Laurie, Jonathan S Serody

Biomaterials· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor microenvironment immunomodulation by nanoformulated TLR 7/8 agonist and PI3k delta inhibitor enhances therapeutic benefits of radiotherapy.
Mostafa Yazdimamaghani, Oleg V Kolupaev, Chaemin Lim, Duhyeong Hwang, Sonia J Laurie, Jonathan S Serody

Biomaterials· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Prevalence of Multidrug Resistance in Enterobacterales Is Higher in Patients Undergoing Hematopoietic Stem Cell Transplantation.
Tessa M Andermann, Dylan Brown, Thomas Holowka, Luther A Bartelt, Jonathan S Serody

Open Forum Infect Dis· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimized Fabrication of Dendritic Mesoporous Silica Nanoparticles as Efficient Delivery System for Cancer Immunotherapy.
Varsha Godakhindi, Mostafa Yazdimamaghani, Sudip Kumar Dam, Farzana Ferdous, Andrew Z Wang, Jonathan Serody

Small· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type II innate lymphoid cell plasticity contributes to impaired reconstitution after allogeneic hematopoietic stem cell transplantation.
Sonia J Laurie, Joseph P Foster, Danny W Bruce, Hemamalini Bommiasamy, Oleg V Kolupaev, Jonathan S Serody

Nat Commun· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infectious Complications Following CD30 Chimeric Antigen Receptor T-Cell Therapy in Adults.
Felicia Cao, Yueling Xiu, Michael Mohnasky, Jonathan S Serody, Paul Armistead

medRxiv· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-CD30 CAR T cells as consolidation after autologous haematopoietic stem-cell transplantation in patients with high-risk CD30 lymphoma: a phase 1 study.
Natalie S Grover, George Hucks, Marcie L Riches, Anastasia Ivanova, Dominic T Moore, Jonathan S Serody

Lancet Haematol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune features are associated with response to neoadjuvant chemo-immunotherapy for muscle-invasive bladder cancer.
Wolfgang Beckabir, Mi Zhou, Jin Seok Lee, Steven P Vensko, Mark G Woodcock, Jonathan S Serody

Nat Commun· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting PRMT9-mediated arginine methylation suppresses cancer stem cell maintenance and elicits cGAS-mediated anticancer immunity.
Haojie Dong, Xin He, Lei Zhang, Wei Chen, Yi-Chun Lin, Jonathan Serody

Nat Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor microenvironment immunomodulation by nanoformulated TLR 7/8 agonist and PI3k delta inhibitor enhances therapeutic benefits of radiotherapy.
Mostafa Yazdimamaghani, Oleg V Kolupaev, Chaemin Lim, Duhyeong Hwang, Sonia J Laurie, Jonathan S Serody

bioRxiv· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FGFR inhibition augments anti-PD-1 efficacy in murine FGFR3-mutant bladder cancer by abrogating immunosuppression.
Atsushi Okato, Takanobu Utsumi, Michela Ranieri, Xingnan Zheng, Mi Zhou, Jonathan S Serody

J Clin Invest· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A tissue-intrinsic IL-33/EGF circuit promotes epithelial regeneration after intestinal injury.
Marco Calafiore, Ya-Yuan Fu, Paola Vinci, Viktor Arnhold, Winston Y Chang, Jonathan Serody

Nat Commun· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enforced gut homing of murine regulatory T cells reduces early graft-versus-host disease severity.
Jemma H Larson, Sujeong Jin, Michael Loschi, Sara Bolivar Wagers, Govindarajan Thangavelu, Jonathan S Serody

Am J Transplant· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported outcomes in CD30-directed CAR-T cells against relapsed/refractory CD30+ lymphomas.
Nicholas P Tschernia, Hillary Heiling, Allison M Deal, Catherine Cheng, Caroline Babinec, Jonathan S Serody

J Immunother Cancer· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of a Dual-Epitope Dendritic Cell Vaccine as Part of Combined Immunotherapy for HER2-Expressing Breast Tumors.
Benjamin G Vincent, Danielle M File, Karen P McKinnon, Dominic T Moore, Jeffrey A Frelinger, Jonathan S Serody

J Immunol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of tumor antigen-specific antibody responses in patients with metastatic triple negative breast cancer treated with cyclophosphamide and pembrolizumab.
Eric D Routh, Mark G Woodcock, Wolfgang Beckabir, Steven P Vensko, Jonathan S Serody

J Immunother Cancer· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Landscape of Immune Microenvironments in Racially Diverse Breast Cancer Patients.
Alina M Hamilton, Amber N Hurson, Linnea T Olsson, Andrea Walens, Joseph Nsonwu-Farley, Jonathan S Serody

Cancer Epidemiol Biomarkers Prev· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alphavirus Replicon Particle Vaccine Breaks B Cell Tolerance and Rapidly Induces IgG to Murine Hematolymphoid Tumor Associated Antigens.
Hsuan Su, Kazuhiro Imai, Wei Jia, Zhiguo Li, Rachel A DiCioccio, Jonathan S Serody

Front Immunol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BET-bromodomain and EZH2 inhibitor-treated chronic GVHD mice have blunted germinal centers with distinct transcriptomes.
Michael C Zaiken, Ryan Flynn, Katelyn G Paz, Stephanie Y Rhee, Sujeong Jin, Jonathan S Serody

Blood· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the efficacy of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancer.
Carey K Anders, Mark G Woodcock, Amanda E D Van Swearingen, Dominic T Moore, Maria J Sambade, Jonathan S Serody

J Immunother Cancer· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis